Danilo D'Alessandro - 17 Feb 2026 Form 4 Insider Report for ClearPoint Neuro, Inc. (CLPT)

Reporting relationship: Chief Financial Officer
Issuer ticker: CLPT
Reported as of: 17 Feb 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 19 Feb 2026, 16:09:45 UTC
Prior SEC filing: 05 Jan 2026
Next SEC filing: 05 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Danilo D'Alessandro

Key filing fact

Danilo D'Alessandro filed Form 4 for ClearPoint Neuro, Inc. (CLPT) on 19 Feb 2026.

Key facts

This page summarizes Danilo D'Alessandro's Form 4 filing for ClearPoint Neuro, Inc. (CLPT).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 19 Feb 2026, 16:09.

Change

Previous filing in this sequence was filed on 05 Jan 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001825163 Primary reporting owner

D'Alessandro Danilo

Relationship: Chief Financial Officer
Address: C/O CLEARPOINT NEURO, INC., 120 S. SIERRA AVE., SUITE 100, SOLANA BEACH
Signature: /s/ Danilo D'Alessandro
Signature date: 19 Feb 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CLPT transaction Derivative

Restricted Stock Units

Award

Transaction value: $0
Shares: +66,273
Change %
Price: $0.000000
Shares after: 66,273
Date: 17 Feb 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 66,273
Exercise price
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each restricted stock unit represents a contingent right to receive one share of CLPT common stock.

Footnote F2

The restricted stock units vest as follows: (i) 20% of the total shares on February 17, 2027; (ii) 40% of the total shares on February 17, 2028; and (iii) 40% of the total shares on February 17, 2029.